On Saturday, March 24th, 2012, Adam C. Powell, Ph.D. and Di Wu, B.Pharm., Ph.D., FCP will speak at the 2012 Intercollegiate US-China Healthcare Conference. The Philadelphia-based conference is jointly sponsored by Global China Connection and the Penn Biotech Group, and will feature a closing keynote by Sheldon Dorenfest, founder of The Dorenfest Group.
Dr. Powell’s speech will be on the future of the Chinese healthcare system. In 2009, a year before the U.S. passed the Affordable Care Act, China released a healthcare reform plan of its own. The Chinese reform contained both changes to be made from 2009-2011 and from 2011-2020. Dr. Powell will review the progress to date, highlight changes planned for the future, and compare the reform to the contemporaneous reform occurring in the U.S. Dr. Wu will speak on a panel discussing the future of clinical research and pharmacology in China. China’s healthcare reform is substantially impact both how medicines are manufactured and dispensed.